John E. Monahan
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Gastrointestinal Tumor Research and Treatment, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Prostate Cancer Treatment and Research
Most-Cited Works
- → The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity(2012)8,404 cited
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- → An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)(2013)558 cited
- → Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma(2010)553 cited
- → FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor(2012)360 cited
- → Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma(2013)328 cited
- → Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms(2011)261 cited
- → Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the rat.(1983)201 cited
- → Rapid changes in the concentration of phosphoenolpyruvate carboxykinase mRNA in rat liver and kidney. Effects of insulin and cyclic AMP.(1982)199 cited
- → A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients(2011)133 cited